New UK research reveals that obesity significantly worsens pain, mobility, and daily functioning in older adults with knee ...

Early-onset colorectal cancer is the second deadliest form in the UK, and the average Briton drinks nearly a can a day ...

Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity treatment more than tripled among US adults without diabetes between 2018 and ...

Metabolic syndrome components were associated with higher odds of sleep apnea symptoms among adolescents and young adults in the US.

Currently, more than 42% of adults in the United States have obesity. Among young people, about 1 in 5 adolescents are also ...

A decision is expected in the fourth quarter of 2025.

When you go in for a wellness exam, oftentimes the first things the medical assistant does is take your height and weight.

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...

Obesity and poor diet quality are major issues among adults with severe mental illness, and current weight management ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.